Viruses 2011, 3(7), 982-1000; doi:10.3390/v3070982

Correlates of Immunity to Filovirus Infection

United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland, MD 21702, USA
* Author to whom correspondence should be addressed.
Received: 14 April 2011; in revised form: 14 June 2011 / Accepted: 16 June 2011 / Published: 27 June 2011
(This article belongs to the Special Issue Pathogenesis of Emerging and Re-Emerging RNA Viruses)
PDF Full-text Download PDF Full-Text [173 KB, uploaded 27 June 2011 15:34 CEST]
Abstract: Filoviruses can cause severe, often fatal hemorrhagic fever in humans. Recent advances in vaccine and therapeutic drug development have provided encouraging data concerning treatment of these infections. However, relatively little is known about immune responses in fatal versus non-fatal filovirus infection. This review summarizes the published literature on correlates of immunity to filovirus infection, and highlights deficiencies in our knowledge on this topic. It is likely that there are several types of successful immune responses, depending on the type of filovirus, and the presence and timing of vaccination or drug treatment.
Keywords: filovirus; ebola; marburg; immunity

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Bradfute, S.B.; Bavari, S. Correlates of Immunity to Filovirus Infection. Viruses 2011, 3, 982-1000.

AMA Style

Bradfute SB, Bavari S. Correlates of Immunity to Filovirus Infection. Viruses. 2011; 3(7):982-1000.

Chicago/Turabian Style

Bradfute, Steven B.; Bavari, Sina. 2011. "Correlates of Immunity to Filovirus Infection." Viruses 3, no. 7: 982-1000.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert